Cargando…

Crystal structure of pirfenidone (5-methyl-1-phenyl-1H-pyridin-2-one): an active pharmaceutical ingredient (API)

The crystal structure of pirfenidone, C(12)H(11)NO [alternative name: 5-methyl-1-phenylpyridin-2(1H)-one], an active pharmaceutical ingredient (API) approved in Europe and Japan for the treatment of Idiopathic pulmonary fibrosis (IPF), is reported here for the first time. It was crystallized from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbero, Mauro, Mossotti, Matteo, Sironi, Angelo, Giovenzana, Giovanni Battista, Colombo, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union of Crystallography 2019
Materias:	Research Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659322/ https://www.ncbi.nlm.nih.gov/pubmed/31392009 http://dx.doi.org/10.1107/S2056989019006418

Ejemplares similares

The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry
por: Baumann, Marcus, et al.
Publicado: (2015)

Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs)
por: Souto, Eliana B., et al.
Publicado: (2021)

Solvatomorphism of Moxidectin
por: Grell, Toni, et al.
Publicado: (2021)

Active pharmaceutical ingredient (API) chemicals: a critical review of current biotechnological approaches
por: Kumar, Vinod, et al.
Publicado: (2022)

A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs
por: Suchomel, Ashley, et al.
Publicado: (2018)

Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
por: Moodley, Kuveneshan, et al.
Publicado: (2018)

Crystal structure of phenyl(pyridin-2-yl)methanol
por: Kim, Haneol, et al.
Publicado: (2014)

Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs): Nanostructure of the Glassy State Studied by Electron Paramagnetic Resonance Spectroscopy
por: Bakulina, Olga D., et al.
Publicado: (2022)

RP-HPLC and UV Spectrophotometric Methods for Estimation of Pirfenidone in Pharmaceutical Formulations
por: Parmar, V. K., et al.
Publicado: (2014)

Designer Gelators for the Crystallization of a Salt Active Pharmaceutical Ingredient—Mexiletine Hydrochloride
por: Andrews, Jessica L., et al.
Publicado: (2022)

Crystal structure of fac-[2-(4-methyl-5-phenylpyridin-2-yl)phenyl-κ(2) C (1),N]bis[2-(pyridin-2-yl)phenyl-κ(2) C (1),N]iridium(III)
por: Lee, Chi-Heon, et al.
Publicado: (2016)

Crystal structure of 3-(morpholin-4-yl)-1-phenyl-3-(pyridin-2-yl)propan-1-one
por: Ahamed, F. M. Mashood, et al.
Publicado: (2015)

Redetermined structure of 4,4′-bipyridine–1,4-phenylenediacetic acid (1/1) co-crystal
por: Paul, Rima, et al.
Publicado: (2015)

Chemical Engineering in the Pharmaceutical Industry, Active Pharmaceutical Ingredients
por: Ende, David
Publicado: (2019)

Co-Crystals: A Novel Approach to Modify Physicochemical Properties of Active Pharmaceutical Ingredients
por: Yadav, A. V., et al.
Publicado: (2009)

Sample Preparation of Posaconazole Oral Suspensions for Identification of the Crystal Form of the Active Pharmaceutical Ingredient
por: Lykouras, Michail, et al.
Publicado: (2020)

Crystal structure of dichloridobis[2-(phenyldiazenyl)pyridine-κN (1)]zinc
por: Vittaya, Luksamee, et al.
Publicado: (2015)

Spherical crystallization: A technique use to reform solubility and flow property of active pharmaceutical ingredients
por: Chatterjee, Arindam, et al.
Publicado: (2017)

Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients
por: Watson, Oliver L., et al.
Publicado: (2021)

Pirfenidone: is it tolerable?
por: Lara, Abigail, et al.
Publicado: (2016)

Crystal structure of 1-phenylimido-1-{6-[1-(phenylimino)ethyl]pyridin-2-yl}ethan-1-yl-κ(3) N,N′,N′′)iron(II)
por: Lau, Ka-Cheong, et al.
Publicado: (2016)

Crystal structure of the pyridine–diiodine (1/1) adduct
por: Tuikka, Matti, et al.
Publicado: (2015)

Crystal structure of chlorido(2-{[2-(phenylcarbamothioyl)hydrazin-1-ylidene](pyridin-2-yl)methyl}pyridin-1-ium)gold(I) chloride sesquihydrate
por: Gatto, Claudia C., et al.
Publicado: (2015)

Microbatch under-oil salt screening of organic cations: single-crystal growth of active pharmaceutical ingredients
por: Babor, Martin, et al.
Publicado: (2019)

Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing
por: Stocker, Michael W., et al.
Publicado: (2022)

2-Phenylimidazo[1,2-a]pyridine-3-carbaldehyde
por: Anaflous, Abderrahman, et al.
Publicado: (2008)

Crystal structure of (pyridin-2-ylmethylidene)(triphenylmethyl)amine
por: Theppitak, Chatphorn, et al.
Publicado: (2014)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
por: De Groot, Anne S., et al.
Publicado: (2013)

Structure of the active pharmaceutical ingredient bismuth subsalicylate
por: Svensson Grape, Erik, et al.
Publicado: (2022)

Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients
por: Cores, Ángel, et al.
Publicado: (2022)

2-(Phenylselenonyl)pyridine
por: Gulati, Shivani, et al.
Publicado: (2013)

Crystal structure of (4-cyanopyridine-κN){5,10,15,20-tetrakis[4-(benzoyloxy)phenyl]porphyrinato-κ(4) N}zinc–4-cyanopyridine (1/1)
por: Nasri, Soumaya, et al.
Publicado: (2016)

2-Benzyl-3-phenyl-1-(pyridin-2-yl)propan-1-one
por: Naveed Umar, Muhammad, et al.
Publicado: (2012)

Crystal structure and Hirshfeld surface analysis of 2-oxo-2-phenylethyl 3-nitroso-2-phenylimidazo[1,2-a]pyridine-8-carboxylate
por: El Kalai, Fouad, et al.
Publicado: (2022)

Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?
por: Latella, Giovanni, et al.
Publicado: (2020)

Crystal structure of dichlorido{2,6-bis[(3-phenyl-1H-pyrazol-1-yl)methyl]pyridine}cobalt(II)
por: Son, Kyung-sun, et al.
Publicado: (2015)

Crystal structure of 3-methyl-1-phenyl-6-propylamino-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile
por: Jasinski, Jerry P., et al.
Publicado: (2015)

2,6-Bis[1-(2-isopropylphenylimino)ethyl]pyridine
por: Agrifoglio, Giuseppe, et al.
Publicado: (2007)

Understanding flow chemistry for the production of active pharmaceutical ingredients
por: Burange, Anand S., et al.
Publicado: (2022)

Efficient Screening of Coformers for Active Pharmaceutical Ingredient Cocrystallization
por: Sugden, Isaac J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4clltgfiis30lrb6a0i4erke7s